載入...
Treatment options in myocarditis and inflammatory cardiomyopathy: Focus on i. v. immunoglobulins
For myocarditis and inflammatory cardiomyopathy, an etiologically driven treatment is today the best option beyond heart failure therapy. Prerequisites for this are noninvasive and invasive biomarkers including endomyocardial biopsy and polymerase chain reaction on cardiotropic agents. Imaging by Do...
Na minha lista:
| 發表在: | Herz |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer Medizin
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6096625/ https://ncbi.nlm.nih.gov/pubmed/29947834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00059-018-4719-x |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|